90 related articles for article (PubMed ID: 28942994)
1. Impact of organized and opportunistic Pap testing on the risk of cervical cancer in young women - A case-control study from Finland.
Makkonen P; Heinävaara S; Sarkeala T; Anttila A
Gynecol Oncol; 2017 Dec; 147(3):601-606. PubMed ID: 28942994
[TBL] [Abstract][Full Text] [Related]
2. Age-specific effectiveness of the Finnish cervical cancer screening programme.
Lönnberg S; Anttila A; Luostarinen T; Nieminen P
Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1354-61. PubMed ID: 22665576
[TBL] [Abstract][Full Text] [Related]
3. Divergent coverage, frequency and costs of organised and opportunistic Pap testing in Finland.
Salo H; Nieminen P; Kilpi T; Auranen K; Leino T; Vänskä S; Tiihonen P; Lehtinen M; Anttila A
Int J Cancer; 2014 Jul; 135(1):204-13. PubMed ID: 24347441
[TBL] [Abstract][Full Text] [Related]
4. Cervix cancer screening in Croatia within the European Cervical Cancer Prevention Week.
Skopljanac-Macina L; Mahovlić V; Ovanin-Rakić A; Barisić A; Rajhvajn S; Juric D; Babić D; Corusić A; Oresković S
Coll Antropol; 2010 Jun; 34(2):613-7. PubMed ID: 20698138
[TBL] [Abstract][Full Text] [Related]
5. Impact of opportunistic testing in a systematic cervical cancer screening program: a nationwide registry study.
Tranberg M; Larsen MB; Mikkelsen EM; Svanholm H; Andersen B
BMC Public Health; 2015 Jul; 15():681. PubMed ID: 26194007
[TBL] [Abstract][Full Text] [Related]
6. Mortality audit of the Finnish cervical cancer screening program.
Lönnberg S; Nieminen P; Luostarinen T; Anttila A
Int J Cancer; 2013 May; 132(9):2134-40. PubMed ID: 22987437
[TBL] [Abstract][Full Text] [Related]
7. Pap smear screening, pap smear abnormalities and psychosocial risk factors among women in a residential alcohol and drug rehabilitation facility.
Soccio J; Brown M; Comino E; Friesen E
J Adv Nurs; 2015 Dec; 71(12):2858-66. PubMed ID: 26279461
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of an organized cervical cancer screening program in Korea: results from a cohort study.
Jun JK; Choi KS; Jung KW; Lee HY; Gapstur SM; Park EC; Yoo KY
Int J Cancer; 2009 Jan; 124(1):188-93. PubMed ID: 18785204
[TBL] [Abstract][Full Text] [Related]
9. Risk of cervical cancer after a negative Pap smear.
Viikki M; Pukkala E; Hakama M
J Med Screen; 1999; 6(2):103-7. PubMed ID: 10444730
[TBL] [Abstract][Full Text] [Related]
10. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer case-control audit: Results from routine evaluation of a nationwide cervical screening program.
Wang J; Elfström KM; Andrae B; Nordqvist Kleppe S; Ploner A; Lei J; Dillner J; Sundström K; Sparén P
Int J Cancer; 2020 Mar; 146(5):1230-1240. PubMed ID: 31107987
[TBL] [Abstract][Full Text] [Related]
12. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
[TBL] [Abstract][Full Text] [Related]
13. Cervical and breast cancer screening participation for women with chronic conditions in France: results from a national health survey.
Constantinou P; Dray-Spira R; Menvielle G
BMC Cancer; 2016 Mar; 16():255. PubMed ID: 27029643
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of screening in preventing cervical cancer among older women.
Kamineni A; Weinmann S; Shy KK; Glass AG; Weiss NS
Cancer Causes Control; 2013 Sep; 24(9):1653-60. PubMed ID: 23744043
[TBL] [Abstract][Full Text] [Related]
15. Cervical screening participation and risk among Swedish-born and immigrant women in Sweden.
Azerkan F; Sparén P; Sandin S; Tillgren P; Faxelid E; Zendehdel K
Int J Cancer; 2012 Feb; 130(4):937-47. PubMed ID: 21437898
[TBL] [Abstract][Full Text] [Related]
16. Pap test use and cervical cancer incidence in First Nations women living in Manitoba.
Decker KM; Demers AA; Kliewer EV; Biswanger N; Musto G; Elias B; Griffith J; Turner D
Cancer Prev Res (Phila); 2015 Jan; 8(1):49-55. PubMed ID: 25403849
[TBL] [Abstract][Full Text] [Related]
17. Screening for cervical cancer in French Guiana: screening rates from 2006 to 2011.
Douine M; Roué T; Lelarge C; Adenis A; Thomas N; Nacher M
Bull Soc Pathol Exot; 2015 Dec; 108(5):355-9. PubMed ID: 26608273
[TBL] [Abstract][Full Text] [Related]
18. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France.
Sancho-Garnier H; Tamalet C; Halfon P; Leandri FX; Le Retraite L; Djoufelkit K; Heid P; Davies P; Piana L
Int J Cancer; 2013 Dec; 133(11):2681-7. PubMed ID: 23712523
[TBL] [Abstract][Full Text] [Related]
19. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
[TBL] [Abstract][Full Text] [Related]
20. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
